Novanta Beats Q2 Expectations with 3% Revenue Growth
Novanta Inc. surpasses market expectations with a 3% revenue growth in Q2 2024. Adjusted EBITDA and operating cash flow also ...
- Latest
- Trending
Novanta Inc. surpasses market expectations with a 3% revenue growth in Q2 2024. Adjusted EBITDA and operating cash flow also ...
TG Therapeutics' Q2 2024 results show BRIUMVI sales at $72.6M, prompting a revenue guidance raise to $290-$300M.
After-hours trading saw significant moves with Airbnb, Super Micro, and Lumen Technologies among the notable movers.
Airbnb shares drop 13% following a disappointing Q3 revenue forecast, despite beating Q2 revenue estimates. Consumer headwinds affect demand.
Semler Scientific adopts bitcoin strategy after studying MicroStrategy. Plans to invest more with SEC approval for capital raise.
"Semler Scientific Q2 2024: Strong operations despite 22% revenue dip, spotlight on Bitcoin investment as inflation hedge and strategic growth ...
Gaia Inc. reports an 11% revenue boost, introduces Gaia Marketplace, invests in health tech, and forecasts growth despite financial hurdles.
Clover Health reports its first-ever positive net income in Q2 2024, driven by financial growth and a technology-driven care platform.
Unveil Tesla’s financial health and stock predictions. Explore critical insights into earnings, risks, and market trends in our detailed report.
Explore NVIDIA's financial performance with Terry Bingman’s incisive report. Delve into stock trends, revenue growth, and future projections. Read more!
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.